Polocaine Injection, Solution
Product Images NDC 63323-283

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Polocaine (NDC 63323-283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Pol09 0002 01)

Chemical structure of Mepivacaine Hydrochloride, the active ingredient in Polocaine injection solution. The diagram shows the molecular composition including a piperidine ring, amide linkage, methyl groups, benzene ring, and hydrochloride moiety.*

FDA Label Image

Fresenius Kabi Logo (Pol09 0002 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Polocaine®–MPF 30 mL Single Dose Vial Label)

Label for Polocaine-MPF (mepivacaine HCl injection, USP) 1% solution, providing 10 mg/mL strength with 300 mg per 30 mL vial. Single dose vial intended for nerve block, caudal, epidural, and infiltration anesthesia; not for spinal anesthesia or dental use. Methylparaben free, labeled for prescription use only. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Polocaine-MPF (mepivacaine HCl injection, USP) 1% solution at 10 mg/mL strength. The label states the total amount as 300 mg per 30 mL vial. It is indicated for nerve block, caudal, epidural, and infiltration anesthesia but not intended for spinal or dental use. The package contains 25 single-dose vials of 30 mL each, labeled by Fresenius Kabi USA, LLC. Additional ingredients and storage conditions are also provided on the label.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Polocaine (mepivacaine HCl Injection, USP) 1% solution for injection, 10 mg/mL strength, in a 50 mL multiple dose vial. The label states the drug is for infiltration and nerve block only, not intended for spinal anesthesia or dental use. It is manufactured by Fresenius Kabi USA, LLC and provides storage instructions at 20-25°C (68-77°F).*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Polocaine 1% (mepivacaine HCl Injection, USP) is shown in a label for a 50 mL multiple dose vial, containing 500 mg per 50 mL (10 mg per mL) solution for infiltration and nerve block. The label notes it is not intended for spinal anesthesia or dental use and is Rx only. The labeler is Fresenius Kabi USA, LLC with storage instructions and ingredient details included.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Polocaine-MPF (mepivacaine HCl Injection, USP) 1.5% injection solution containing 450 mg per 30 mL (15 mg/mL). It is a 30 mL single dose vial labeled for nerve block, caudal, epidural, and infiltration anesthesia. The label states methylparaben free and indicates storage at 20° to 25°C. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Polocaine-MPF 1.5% (mepivacaine HCl injection) 450 mg per 30 mL (15 mg/mL) solution for injection by infiltration. Contains 25 single dose vials of 30 mL each. Intended for nerve block, caudal, epidural, and infiltration anesthesia. Free of methylparaben and preservatives, manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Polocaine-MPF (mepivacaine HCl Injection, USP) 2% solution with a strength of 20 mg/mL, provided as 20 mL single dose vial. Indicated for nerve block, caudal, epidural, and infiltration anesthesia, and labeled as methylparaben free. The label includes storage instructions and the manufacturer Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Polocaine-MPF 2% (Mepivacaine HCl Injection, USP) injection solution, 20 mg/mL strength, in 20 mL single-dose vials. The label indicates a 25 vial package for nerve block, caudal, epidural, and infiltration anesthesia. Manufactured by Fresenius Kabi USA, LLC. The label includes ingredient amounts per mL and storage instructions.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Polocaine 20 mg/mL (2%) mepivacaine hydrochloride injection, USP in a 50 mL multiple dose vial. The label states it is for infiltration and nerve block only, not for spinal anesthesia or dental use. It is labeled as Rx only and produced by Fresenius Kabi USA, LLC. Storage temperature instructions and a barcode are also visible.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Polocaine (mepivacaine HCl injection, USP) 2% solution, providing 1,000 mg per 50 mL (20 mg/mL) strength. The vial is intended for infiltration and nerve block use only and is not for spinal anesthesia or dental use. The package contains 25 multiple dose vials of 50 mL each. Manufactured by Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.